Comparison of risankizumab and apremilast for the treatment of adults with moderate plaque psoriasis eligible for systemic therapy: results from a randomized, open-label, assessor-blinded phase IV…

Overview of attention for article published in British Journal of Dermatology, July 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#43 of 9,683)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 49 news outlets
blogs: 1 blog

twitter: 4 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 10 Mendeley

Summary News Blogs X Dimensions citations

So far, Dimensions has found 4 publications that cite this research output.

4

The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.

The Role of Interleukin 23/17 Axis in Psoriasis Management: A Comprehensive Review of Clinical Trials

Article in Clinical Cosmetic and Investigational Dermatology (April 2024)

Phosphodiesterase-4 Inhibition in the Management of Psoriasis

Article in Pharmaceutics (December 2023)

Phosphodiesterase 4 Inhibition in the Management of Psoriasis

Preprint in Preprints.org (November 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.